AstraZeneca, Merck, Novo deals inject fresh global momentum into Chinese biotech
- Posted on September 29, 2026
- By South China Morning Post
- 1 Views
- 1 min read
In brief
Generating AI summary…
AstraZeneca, Merck, Novo deals inject fresh global momentum into Chinese biotech
Deals involving novel cancer therapies and weight-loss drugs reinforce the growing global appeal of Chinese biotech innovation.
